Besivance 0.006 Eye drops. suspension

Besivance 0.006 Eye drops. suspension

S4
PDF Leaflet Revision Date: 22 September 2020

API: Besifloxacin | Company: Soflens

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of bacterial conjunctivitis in patients aged one year and older.

Dosage (summary)

1 drop in affected eye(s) 3 times a day for 7 days.

Special Populations

  • Paediatric patients under 1 year
  • Elderly

Pregnancy & Breastfeeding

Limited data; low systemic exposure; caution advised during breastfeeding.

Contraindications

  • Hypersensitivity to besifloxacin or ingredients

Common side effects

  • Conjunctival redness
  • Blurred vision
  • Eye pain
  • Eye irritation
  • Headache

Counselling Points

  • Avoid contact lenses during treatment
  • May cause temporary blurred vision

Serious warnings

  • Not for injection
  • Risk of resistant organisms with prolonged use
  • Caution in dry eye patients
Important Disclaimer

The Besivance 0.006 Eye drops. suspension professional information leaflet below is the property of Soflens and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites